June 2024 in “British Journal of Dermatology” This study observed that some patients experienced alopecia areata during dupilumab treatment for atopic dermatitis, but many regrew hair while continuing therapy.
July 2022 in “British Journal of Dermatology” This systematic review observed that Janus kinase inhibitors show promising efficacy for treating alopecia areata, but more studies on adolescent treatments and patient-relevant outcomes are needed.
June 2024 in “British Journal of Dermatology” This study reports that among patients treated with dupilumab, a minority developed new-onset alopecia areata, but the majority experienced hair regrowth despite continuing the treatment.
June 2023 in “British Journal of Dermatology” In this case series, researchers observed a rare presentation of lichen planopilaris confined to the face in six patients, with dermoscopic and histopathological profiles indicating scarring alopecia and pigment changes, and suggested that shaving and mustard oil use might trigger the condition.
18 citations
,
August 2015 in “Biochemical and Biophysical Research Communications” This study found that the XEDAR receptor can activate the non-canonical NF-kB pathway involving p100 processing, which is regulated by interactions with TRAF proteins and specific kinases.